AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACRUX LTD

0.010

+0.00111.11%

Volume:232.47K

Turnover:2K

Market Cap:5.90M

PE:-1.73

High:0.010

Open:0.010

Low:0.010

Close:0.009

52wk High:0.021

52wk Low:0.009

Shares:589.68M

Float Shares:300.39M

Volume Ratio:0.27

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.006

EPS(LYR):-0.017

ROE:-102.19%

ROA:-57.22%

PB:4.91

PE(LYR):-0.59

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+2.85%

Capital Flow

Inflow:

Outflow:

News

Acrux Ltd-Acrux Appoints Chief Medical Officer

THOMSON REUTERS

Acrux Ltd-Update - Licensing Lenzetto for Australia for AUD5.4m

THOMSON REUTERS

Acrux Ltd - Licenses Lenzetto for Australian Market for AUD 5.4 Mln

THOMSON REUTERS

BRIEF-Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/ACR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","market":"AU","secType":"STK","nameCN":"ACRUX LTD","latestPrice":0.01,"timestamp":1787638320000,"preClose":0.009,"halted":0,"volume":232468,"delay":0,"changeRate":0.11111111111111122,"nameEN":"ACRUX LTD","floatShares":300389644,"shares":589677802,"eps":-0.005785,"marketStatus":"Not Yet Opened","change":0.001,"latestTime":"08-25 16:12:00 AEST","open":0.01,"high":0.01,"low":0.01,"amount":2325,"amplitude":0,"askPrice":0.011,"askSize":100000,"bidPrice":0.01,"bidSize":575224,"shortable":3,"etf":0,"ttmEps":-0.005785,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.009,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.266659,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACR.AU","preClose":0.01,"auctionPrice":0.009,"auctionVolume":12130,"auction":3,"marketStatus":"盘后竞价","timestamp":1787551260130}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","floatShares":300389644,"roa":"-57.22%","roe":"-102.19%","lyrEps":-0.016881,"volumeRatio":0.266659,"shares":589677802,"dividePrice":0,"high":0.01,"amplitude":0,"preClose":0.009,"low":0.01,"week52Low":0.009,"pbRate":"4.91","psRate":"2.10","week52High":0.021,"institutionHeld":0,"latestPrice":0.01,"committee":0.703802,"eps":-0.005785,"divideRate":0,"volume":232468,"delay":0,"ttmEps":-0.005785,"open":0.01,"prevYearClose":0.015,"prevWeekClose":0.01,"prevMonthClose":0.01,"prevQuarterClose":0.012,"fiveDayClose":0.01,"twentyDayClose":0.011,"sixtyDayClose":0.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"ACR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708606800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661249246","title":"Acrux Ltd-Acrux Appoints Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661249246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661249246?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:44","pubTimestamp":1787528698,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nTUE6TLHP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ACR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639083648","title":"Acrux Ltd-Update - Licensing Lenzetto for Australia for AUD5.4m","url":"https://stock-news.laohu8.com/highlight/detail?id=2639083648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639083648?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:19","pubTimestamp":1780021181,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUE8R8SS8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ACR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638463477","title":"Acrux Ltd - Licenses Lenzetto for Australian Market for AUD 5.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2638463477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638463477?lang=en_us&edition=fundamental","pubTime":"2026-05-28 07:05","pubTimestamp":1779923124,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN42416B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638571400","title":"BRIEF-Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2638571400","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638571400?lang=en_us&edition=fundamental","pubTime":"2026-05-27 14:35","pubTimestamp":1779863714,"startTime":"0","endTime":"0","summary":"BRIEF-Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia    May 27  - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says in a statement on the Budapest Stock Exchange:AGREES WITH ACRUX ON EXTENSION OF ITS LICENSE AGREEMENT DATED 2013 RELATING TO TRANSDERMAL ESTRADIOL SPRAY LENZETTO TO AUSTRALIAN MARKETAMENDED AGREEMENT PROVIDES RICHTER EXCLUSIVE COMMERCIALIZATION RIGHTS FOR THE AUSTRALIAN MARKETRICHTER SAYS ACRUX WILL RECEIVE TOTAL PAYMENTS OF AUD 5.4 MILLION OVER THE COMING PERIODSource text: [ID:]Further company coverage: GDRB.BU  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nB3N41W00G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}